New stent aims to keep dialysis access open longer

NCT ID NCT06096142

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests a new drug-coated stent called Solaris DE for dialysis patients whose veins become narrowed or blocked. About 120 participants will either receive the stent plus balloon angioplasty or angioplasty alone. The goal is to see if the stent keeps the vein open longer and reduces complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Solaris DE endoprosthesis (a drug-coated stent)
What this could lead to
If successful, this could provide a more durable treatment for vein blockages in dialysis patients, reducing the need for repeat procedures.
What could go wrong
This is a relatively small, early-stage trial (120 participants) comparing a new device to standard care. The stent may not prove superior or could carry risks like clotting or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RENAL FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Afya Hospital Dia LTDA

    RECRUITING

    Brasília, Federal District, 70390-150, Brazil

  • Hospital Ana Nery

    RECRUITING

    Salvador, Estado de Bahia, 40323-010, Brazil

  • Hospital Universitário Pedro Ernesto - UERJ

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, 20551030, Brazil

  • Hospital das Clínicas da UFMG/EBSERH

    RECRUITING

    Belo Horizonte, Minas Gerais, 30130-100, Brazil

  • Real Hospital Português de Beneficência em Pernambuco

    RECRUITING

    Recife, Pernambuco, 52010-160, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.